Warning: The NCBI web site requires JavaScript to function. more...
Statins as modulators of bone formation.
Edwards CJ, Spector TD.
Arthritis Res. 2002;4(3):151-3. Epub 2002 Jan 21. Review.
Related citations
Statins and bone metabolism.
Horiuchi N, Maeda T.
Oral Dis. 2006 Mar;12(2):85-101. Review.
[Statins and osteoporosis].
Svejda P.
Vnitr Lek. 2006 Dec;52(12):1190-3. Review. Czech.
The role of statins as potential targets for bone formation.
Garrett IR, Mundy GR.
Arthritis Res. 2002;4(4):237-40. Epub 2002 Feb 1. Review.
Statins, fracture risk, and bone remodeling.
Luisetto G, Camozzi V.
J Endocrinol Invest. 2009;32(4 Suppl):32-7. Review.
Statins and bone: myth or reality?
Edwards CJ, Russell RG, Spector TD.
Calcif Tissue Int. 2001 Aug;69(2):63-6. Review.
Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?
Cruz AC, Gruber BL.
Cleve Clin J Med. 2002 Apr;69(4):277-8, 280-2, 287-8. Review.
Statins and bone morphogenetic proteins: new pathways in bone formation.
Edwards CJ.
Ann Acad Med Singapore. 2002 Mar;31(2):245-7.
[Anabolic effects of statin and beta-blocker on bone metabolism].
Taguchi M, Takeuchi Y.
Clin Calcium. 2004 Dec;14(12):89-94. Review. Japanese.
Statins and bone formation.
Garrett IR, Gutierrez G, Mundy GR.
Curr Pharm Des. 2001 May;7(8):715-36. Review.
HMG CoA reductase inhibitors and the skeleton: a comprehensive review.
Bauer DC.
Osteoporos Int. 2003 Jun;14(4):273-82. Epub 2003 May 8. Review.
Statins: under investigation for increasing bone mineral density and augmenting fracture healing.
Tang QO, Tran GT, Gamie Z, Graham S, Tsialogiannis E, Tsiridis E, Linder T, Tsiridis E.
Expert Opin Investig Drugs. 2008 Oct;17(10):1435-63. Review.
The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL, Bleuming SA, Peppelenbosch MP, Hommes DW, van den Brink GR, Hardwick JC.
Gastroenterology. 2007 Oct;133(4):1272-81. Epub 2007 Aug 14.
Skeletal effects of statins.
Yaturu S.
Endocr Pract. 2003 Jul-Aug;9(4):315-20. Review.
HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
Schlienger RG, Meier CR.
Drugs Aging. 2003;20(5):321-36. Review.
Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, Goto J, Yamamura M, Makino H.
J Endocrinol. 2008 Mar;196(3):601-13.
Stimulation of bone formation in vitro and in rodents by statins.
Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G.
Science. 1999 Dec 3;286(5446):1946-9.
Comparison of the effects of D-003, a mixture of high-molecular-weight aliphatic acids from sugarcane wax, and pravastatin on bones and osteoclast apoptosis of ovariectomized rats.
Mendoza S, Noa M, Mas R, Mendoza N.
Drugs Exp Clin Res. 2005;31(5-6):181-91.
[Stimulation of bone formation by statins].
Komatsu Y, Nakao K.
Nihon Rinsho. 2004 Feb;62 Suppl 2:783-8. Review. Japanese. No abstract available.
Statins and osteoporosis: a clinical review.
Gonyeau MJ.
Pharmacotherapy. 2005 Feb;25(2):228-43. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on